Abstract:
Devices including conductometric porous silicon gas sensors, methods of fabricating conductometric porous silicon gas sensors, methods of selecting a device, methods of detecting a concentration of a gas, and methods of analyzing data.
Abstract:
This invention relates generally to the targeting and biopsy of tissue for medical purposes, and more particularly to a targeted biopsy system which allows planning of tissue to be sampled, targeting of specific areas of tissue in reference to the plan, capturing the tissue sample and recording the source location of the tissue sample, particularly for use in collecting tissue samples from the prostate gland. A further purpose of this invention is to provide a targeted treatment system which allows planning of tissue to be treated, targeting of specific areas of tissue in reference to the plan, and delivering the treatment to the targeted tissue.
Abstract:
Apparatus and method for providing ultrasound image and visualization aid that provides control and positioning of the ultrasonic technology and its scanning to furnish a more particular three dimensional graphical image and display during usage. The system provides for the display of an approximation of an organ or tissue mass being scanned, and the position of the image plane of the ultrasound relative to the determined approximation, to allow the ultrasound user to more quickly and accurately determine the location of the ultrasound scan plane in relation to the tissue mass.
Abstract:
Described are a system and method for switching packet traffic over an optical transport network. A network element comprises plurality of mappers for mapping packet traffic to electrical streams. A host network interface includes a packet switch that forwards a first portion of the packet traffic to a first one of the mappers and a second portion of the packet traffic to a second one of the mappers. The first one of the mappers maps the first portion of the packet traffic into a first electrical stream targeted to a first destination on an optical transport network and the second one of the mappers maps the second portion of the packet traffic into a second electrical stream targeted to a second destination on the optical transport network.
Abstract:
A video telecommunications delivery network (10) provides video channels to a plurality of set top units (24). Each set top unit sends a video channel request to an associated cell multiplexing unit (20). If the video channel is available, the cell multiplexing unit (20) provides the video channel to the set top unit (22). If the requested video channel is not available, the cell multiplexing unit (20) passes the request to an associated cell routing unit (18). The cell routing unit (18) provides the requested video channel to the set top unit (22) according to availability. If unavailable, cell routing unit 18 provides the video channel request to a digital multicast bank (16). Digital multicast bank (16) delivers the requested video channel if available, otherwise the video channel request is routed to a video information provider (12) through an asynchronous transfer mode (ATM) switch (14). The video information provider (12) delivers the requested video channel to the digital multi-cast bank (16) through the ATM switch (14) for ultimate delivery to a video subscriber at the set top box.
Abstract:
A nozzle assembly for a fuel injector capable of withstanding high-pressures includes a nozzle chamber defined by a high-pressure containment sleeve, a tip component defining a nozzle outlet, and an injector stack component. A leakage path is defined between an injector body casing and an outer wall surface of the high-pressure containment sleeve and a needle valve member that opens and closes the nozzle outlet is out of contact with the high-pressure containment sleeve. The high-pressure containment sleeve has a hollow, cylindrical shape and has an inner wall exposed to fluid pressure inside the nozzle chamber that is free of stress concentrating surface features associated with heart shaped cavities in the prior art.
Abstract:
A compound of formula Ia or formula Ib, or a pharmaceutically acceptable salt or ester thereof, wherein R1 is selected from: aryl; heteroaryl; —NHR3; fused aryl-C4-7-heterocycloalkyl; —CONR4R5; —NHCOR6; —C3-7-cycloalkyl; -0-C3-7-cycloalkyl; —NR3R6; and optionally substituted —C1-6 alkyl; wherein said aryl, heteroaryl, fused aryl-C4-7-heterocycloalkyl and C4-7-heterocycloalkyl are each optionally substituted; Q is CN, halogen, or is selected from C1-6-alkyl, C3-7-cycloalkyl, heterocycloalkyl, aryl and heteroaryl, each of which is optionally substituted with one or more substituents A; R2 is selected from hydrogen, aryl, C1-6-alkyl, C2-6-alkenyl, C3-7-cycloalkyl, heteroaryl, C4-7-heterocycloalkyl and halogen, wherein said C1-6-alkyl, Cz-B-alkenyl, aryl, heteroaryl and C4-7-heterocycloalkyl are each optionally substituted; R3 is selected from aryl, heteroaryl, C4-7-heterocycloalkyl, C3-7-cycloalkyl, fused aryl-C-heterocycloalkyl and C1-6-alkyl, each of which is optionally substituted; R4 and R5 are each independently hydrogen, or optionally substituted C3-7-cycloalkyl, aryl, heteroaryl, C1-6-alkyl or C3-6-heterocycloalkyl; or R4 and R5 together with the N to which they are attached form a C3-6-heterocycloalkyl ring; each R6 is independently selected from C1-6-alkyl, C3-7-cycloalkyl, C-heterocycloalkyl, aryl and heteroaryl, each of which is optionally substituted; each R7 is selected from hydrogen, optionally substituted C1-6-alkyl and C3-7-cycloalkyl; each of R8 and R9 is independently hydrogen or optionally substituted C1-6-alkyl; or R8 and R9 together with the N to which they are attached form a C4-6-heterocycloalkyl; each R10 is selected from C3-7-cycloalkyl and optionally substituted C1-6-alkyl; each R11 is independently selected from C1-6-alkyl, C3-7-cycloalkyl, C1-6-alkyl-C3-7-cycloalkyl, C4-7-heterocycloalkyl, aryl and heteroaryl, each of which is optionally substituted; A is selected from halogen, —NR4S02R5, —CN, —OR6, —NR4R5, —NR7R11, hydroxyl, —CF3, —CONR4R5, —NR4COR5, —NR7(CO)NR4R5, —N02, —C02H, —C02R6, —S02R6, —S02NR4R5, —NR4COR5, —NR4COOR5, 6-alkyl and —COR6. Further aspects relate to pharmaceutical compositions, therapeutic uses and process for preparing compounds of formulae Ia and Ib.
Abstract:
A valve assembly including an armature and a valve member that are coupled when the solenoid coil is de-energized but are decoupled after the solenoid coil is energized. A first spring biases the armature and the valve member to a closed valve seat position while a second spring having a smaller preload than the first spring biases the valve member to an open valve seat position. When the solenoid coil is energized, the magnetic force of the coil overcomes the force exerted by the first spring pulling the armature away from the valve member. The valve member moves to the open valve seat position by the force exerted by the second spring. When the coil is de-energized, the magnetic force decays, thereby allowing the armature and the valve member to re-couple.
Abstract:
The invention relates to methods and apparatus for forming images on a display utilizing a control matrix to control the movement of MEMs-based light modulators.